Apheresis for babesiosis: Therapeutic parasite reduction or removal of harmful toxins or both?
- 20 October 2015
- journal article
- review article
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 31 (5) , 454-458
Abstract
Babesiosis is a potentially life-threatening illness caused by intraerythrocytic protozoan parasites of the genus Babesia that are transmitted most commonly by Ixodes ticks, and rarely from blood transfusion or congenitally. Clinical presentations of babesiosis include asymptomatic infection, mild to moderate disease, or severe disease. Antibiotics such as atovaquone plus azithromycin or clindamycin and quinine can be used effectively to treat this disease in most cases, however in high risk populations, the mortality rate can be as high as 20% despite therapy. Therapeutic exchange transfusion has been used in severe babesiosis and is of apparent therapeutic benefit. It is not entirely clear through what mechanism therapeutic exchange transfusion may help patients. Data suggests that in addition to parasite load reduction, it is possible that therapeutic exchange transfusion removes toxins generated by babesia infection. There are many remaining questions that need to be addressed regarding exchange transfusion for babesiosis. J. Clin. Apheresis 31:454-458, 2016. © 2015 Wiley Periodicals, Inc.Keywords
This publication has 23 references indexed in Scilit:
- Vertical Transmission of Babesia microti , United StatesEmerging Infectious Diseases, 2012
- TRANSFUSION COMPLICATIONS: Seroprevalence of Babesia microti in blood donors from Babesia‐endemic areas of the northeastern United States: 2000 through 2007Transfusion, 2009
- Red cell exchange transfusion for babesiosis in Rhode IslandJournal of Clinical Apheresis, 2009
- Persistent and Relapsing Babesiosis in Immunocompromised PatientsClinical Infectious Diseases, 2008
- Shared features in the pathobiology of babesiosis and malariaTrends in Parasitology, 2007
- Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American society for apheresisJournal of Clinical Apheresis, 2007
- Demonstrable parasitemia among Connecticut blood donors with antibodies to Babesia microtiTransfusion, 2005
- Severe Babesiosis in Long Island: Review of 34 Cases and Their ComplicationsClinical Infectious Diseases, 2001
- Red Cell Exchange: Treatment of Babesiosis in a Splenectomized PatientTransfusion, 1981
- Treatment of Transfusion-Transmitted Babesiosis by Exchange TransfusionNew England Journal of Medicine, 1980